Last reviewed · How we verify
Oropharyngeal Candidiasis
Approved treatments
- Lotrimin · Bayer AG
- Sporanox · Sebela Ireland Ltd
- Diflucan · Pfizer Inc.
- Fluconazol · Azienda Sanitaria-Universitaria Integrata di Udine
- Monistat · Johnson & Johnson (Janssen)
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Oropharyngeal Candidiasis patent landscape — cliff calendar, originator estates, attackable patents
- Oropharyngeal Candidiasis treatment landscape brief
- Oropharyngeal Candidiasis treatment updates RSS
Frequently asked questions about Oropharyngeal Candidiasis
What drugs treat Oropharyngeal Candidiasis?
Tracked treatments include Lotrimin, Sporanox, Diflucan, Fluconazol, Monistat.
What is the treatment for Oropharyngeal Candidiasis?
Standard treatment for Oropharyngeal Candidiasis includes Lotrimin, Sporanox, Diflucan, Fluconazol, Monistat. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Oropharyngeal Candidiasis patent cliff · Oropharyngeal Candidiasis CI report
- Treatment: Lotrimin · Bayer AG
- Treatment: Sporanox · Sebela Ireland Ltd
- Treatment: Diflucan · Pfizer Inc.
- Treatment: Fluconazol · Azienda Sanitaria-Universitaria Integrata di Udine
- Treatment: Monistat · Johnson & Johnson (Janssen)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing